Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 2ÀÏÂ÷ : 2021-09-11±³À°ÀÏÀÚ : 2021-09-11
±³À°Àå¼Ò : ÄÜ·¡µåÈ£ÅÚ ¼¿ï(¿Â¶óÀÎ º´Çà)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 2ÀÏÂ÷ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ
´ã´çÀÚ : ICoLA2021 »ç¹«±¹
¿¬¶ôó : 02-2135-3618
À̸ÞÀÏ :
secretariat@icola.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 23 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Àü¹®ÀÇ, ±³¼ö : 100,000¿ø / ÀüÀÓÀÇ, Àü°øÀÇ, ±ºÀÇ°ü, ¿¬±¸¿ø, Çлý µî : 4¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-12 Room 1 08:00~08:20 Interim analysis of APOLLO Study: 1 year follow-up results Seung-Woon Rha(Korea University, Korea)
Åä·Ð 09-12 Room 1 08:20~08:30 Discussion ()
±³À°½Ã°£ 09-12 Room 2 08:00~08:20 How to manage vascular health with statin in Korean patient: evidence based medicine LIPILOU Jong-Young Lee(Sungkyunkwan University, Korea)
Åä·Ð 09-12 Room 2 08:20~08:30 Discussion ()
±³À°½Ã°£ 09-12 Room 3 08:00~08:20 CV safety of Alogliptin in T2DM patients Jae Hyoung Par(Korea University, Korea)
Åä·Ð 09-12 Room 3 08:20~08:30 Discussion ()
±³À°½Ã°£ 09-12 Room 1 09:00~09:30 Hypertriglyceridemia: diagnostic and therapeutic implications Alan Remaley(National Institute of Health, USA)
ÈÞ½Ä 09-12 09:30~09:40 Break ()
±³À°½Ã°£ 09-12 Room 1 09:40~10:05 Latest data on siRNA against PCSK9 Masatsune Ogura(Chiba University Graduate School of Medicine, Japan)
±³À°½Ã°£ 09-12 Room 1 10:05~10:30 Patient ion for PCSK9 MAb based therapies Kausik Ray(Imperial College London, UK)
±³À°½Ã°£ 09-12 Room 1 10:30~10:55 Biological effect & clinical benefit of omega-3 PUFA Mi Kyung Kim(Inje University, Korea)
Åä·Ð 09-12 Room 1 10:55~11:20 Discussion ()
±³À°½Ã°£ 09-12 Room 2 09:40~10:05 The metabolic effects of antisense oligonucleotides treatments in dyslipidemia Gissette Reyes-Soffer(Columbia University, USA)
±³À°½Ã°£ 09-12 Room 2 10:05~10:30 Emerging targets for management of dyslipidemia Hun-Jun Park(The Catholic University of Korea, Korea)
±³À°½Ã°£ 09-12 Room 2 10:30~10:55 New PPARalpha agonist Sang Yong Kim(Chosun University, Korea)
Åä·Ð 09-12 Room 2 10:55~11:20 Discussion ()
±³À°½Ã°£ 09-12 Room 3 09:40~10:05 Apolipoprotein C3 as a regulator of triglyceride-rich lipoproteins in diabetes and its complications Jenny E. Kanter(University of Washington, USA)
±³À°½Ã°£ 09-12 Room 3 10:05~10:30 What's new in intracellular lipid trafficking Young Mi Park(Ewha Womans University, Kore)
±³À°½Ã°£ 09-12 Room 3 10:30~10:55 Regulation of TG transfer protein in lipid metabolism Mahmood Hussain(New York University, USA)
Åä·Ð 09-12 Room 3 10:55~11:20 Discussion ()
±³À°½Ã°£ 09-12 Room 4 09:40~10:05 Vitamin D in cardiometabolic disease - the more the better? Yongjoo Park(Chonnam National University, Korea)
±³À°½Ã°£ 09-12 Room 4 10:05~10:30 Systems science in biomedical research regarding obesity and noncommunicable chronic diseases Hong Xue(George Mason University, USA)
±³À°½Ã°£ 09-12 Room 4 10:30~10:55 Nutrition policies to improve diet and reduce health and economic burdens of cardiometabolic diseases: a microsimulation study Yujin Lee(Myongji University, Korea)
Åä·Ð 09-12 Room 4 10:55~11:20 Discussion ()
±³À°½Ã°£ 09-12 Room 5 09:40~10:05 Update on pathophysiology of acute coronary syndrome Hiroyuki Hao(Nihon University, Japan)
±³À°½Ã°£ 09-12 Room 5 10:05~10:30 Recent studies on platelets in atherosclerosis & thrombosis Hisanori Horiuchi(Tohoku University, Japan)
±³À°½Ã°£ 09-12 Room 5 10:30~10:55 Latest therapeutic strategies to modify platelet function Soon Jun Hong(Korea University, Korea)
Åä·Ð 09-12 Room 5 10:55~11:20 Discussion ()
ÈÞ½Ä 09-12 11:20~11:40 Break ()
±³À°½Ã°£ 09-12 Room 1+2+3 11:40~12:10 Genetics/epigenetic approach in studies of lipid metabolism & atherosclerosis Kiran Musunuru (University of Pennsylvania, USA)
±³À°½Ã°£ 09-12 Room 1 12:10~12:30 Lower is better & combination is better [Ezetimibe+Rosuvastatin] Soo Heon Kwak (Seoul National University, Korea)
Åä·Ð 09-12 Room 1 12:30~12:40 Discussion ()
±³À°½Ã°£ 09-12 Room 2 12:10~12:30 Are all statins the same? Ki Hoon Han(University of Ulsan, Korea)
Åä·Ð 09-12 Room 2 12:30~12:40 Discussion ()
±³À°½Ã°£ 09-12 Room 3 12:10~12:30 Why should we consider Rosuvastatin + Ezetimibe fixed dose combination? Jung-Kyu Han(Seoul National University, Korea)
Åä·Ð 09-12 Room 3 12:30~12:40 Discussion ()
±³À°½Ã°£ 09-12 Room 4 12:10~12:30 Controlling dyslipidemia and CV risk with Atorvastatin and Ezetimibe Soon Jun Hong(Korea University, Korea)
Åä·Ð 09-12 Room 4 12:30~12:40 Discussion ()
±³À°½Ã°£ 09-12 Room 1 13:10~13:17 Treatment of enolase-1 antagonist peptide prevents atherosclerosis in LDLR KO mice Vo Hoang Nguyet Dan(Soonchunhyang University, Korea)
±³À°½Ã°£ 09-12 Room 1 13:17~13:24 The potential of macrophage-specific soluble Ninj1 as a therapeutic target in atherosclerosis Sejin Jeon(Ewha Womans University, Korea)
±³À°½Ã°£ 09-12 Room 1 13:24~13:31 Loss of the mixed lineage kinase domain-like protein decreases necrotic core but increases macrophage lipid accumulation in atherosclerosis Adil Rasheed(University of Ottawa Heart Institute, Canada)
±³À°½Ã°£ 09-12 Room 1 13:31~13:38 Endothelial OASL1 deficiency promotes endothelial dysfunction and atherosclerotic plaque formation TaeKyeong Kim(Ewha Womans University, Korea)
±³À°½Ã°£ 09-12 Room 1 13:38~13:45 Macrophage-specific PCSK9 promotes Inflammatory activation after acute myocardial infarction Shin Hye Moon(Ewha Womans University, Korea)
Åä·Ð 09-12 Room 1 13:45~14:10 Q&A ()
±³À°½Ã°£ 09-12 Room 3 13:10~13:17 Intravital two-photon imaging of dynamics of hepatic lipid droplets in fasted and refed state Jieun Moon(Korea Advanced Institute of Science and Technology, Korea)
±³À°½Ã°£ 09-12 Room 3 13:17~13:24 Relative contributions of statin intensity, achieved LDL-C level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes Ji Yoon Kim(Korea University, Korea)
±³À°½Ã°£ 09-12 Room 3 13:24~13:31 Hypertriglyceridemia is an independent risk factor for cardiovascular diseases in Korean adults aged 30-49 years: a nationwide population-based study Bo Kyung Koo(Seoul National University, Korea)
±³À°½Ã°£ 09-12 Room 3 13:31~13:38 Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose Chan Joo Lee(Yonsei University, Korea)
±³À°½Ã°£ 09-12 Room 3 13:38~13:45 Association between dietary acid load and metabolic syndrome risk ? Mi Ri Ha(Dong-A University, Korea)
Åä·Ð 09-12 Room 3 13:45~14:10 Q&A ()
±³À°½Ã°£ 09-12 Room 1+2+3 14:10~14:40 Targeting smooth muscle cell in management of atherosclerotic cardiovascular disease Martin Bennett(University of Cambridge, UK)
ÈÞ½Ä 09-12 14:40~15:00 Break ()
±³À°½Ã°£ 09-12 Room 1 15:00~15:25 Lp(a) as a risk factor Hiroshi Yoshida(Jikei University School of Medicine, Japan)
±³À°½Ã°£ 09-12 Room 1 15:25~15:50 Recent results on Lp(a) therapeutics Sotirios Tsimikas(University of California San Diego, USA)
±³À°½Ã°£ 09-12 Room 1 15:50~16:15 Anti-inflammatory treatment to reduce CV risk Jung Ho Heo(Kosin University, Korea)
Åä·Ð 09-12 Room 1 16:15~16:40 Discussion ()
±³À°½Ã°£ 09-12 Room 2 15:00~15:25 Future of CV risk stratification in FH patients Hayato Tada(Kanazawa University, Japan)
±³À°½Ã°£ 09-12 Room 2 15:25~15:50 Current trend in treatment of HeFH/HoFH Dirk Blom(Hatter Institute for Cardiovascular Research in Africa, South Africa)
±³À°½Ã°£ 09-12 Room 2 15:50~16:15 Upcoming treatment agents for FH Sang-Hyun Kim(Seoul National University, Korea)
Åä·Ð 09-12 Room 2 16:15~16:40 Discussion ()
±³À°½Ã°£ 09-12 Room 3 15:00~15:25 Beyond HDL-cholesterol: the search for functional biomarkers of HDL Arnold von Eckardstein(University of Zürich, Switzerland)
±³À°½Ã°£ 09-12 Room 3 15:25~15:50 HDL and the cardiovascular risk in diabetes Tomas Vaisar(University of Washington, USA)
±³À°½Ã°£ 09-12 Room 3 15:50~16:15 What¡¯s new in HDL-modifying therapeutics? Jang Hoon Lee(Kyungpook National University, Korea)
Åä·Ð 09-12 Room 3 16:15~16:40 Discussion ()
±³À°½Ã°£ 09-12 Room 4 15:00~15:25 Function of miR-33a/b in lipid and systemic metabolism Koh Ono(Kyoto University, Japan)
±³À°½Ã°£ 09-12 Room 4 15:25~15:50 Non-coding RNA control of cholesterol metabolism and atherosclerosis Katey Rayner(University of Ottawa, Canada)
±³À°½Ã°£ 09-12 Room 4 15:50~16:15 The role of non-coding RNAs in vascular smooth muscle cells Young-Kook Kim(Chonnam National University, Korea)
Åä·Ð 09-12 Room 4 16:15~16:40 Discussion ()
±³À°½Ã°£ 09-12 Room 5 15:00~15:20 REvisiting lipids in REtinal diseases : a focused review on age-related macular degeneration and diabetic retinopathy Dong Ho Park(Kyungpook National University, Korea)
±³À°½Ã°£ 09-12 Room 5 15:20~15:40 The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews Geun Joo Choi(Chung-Ang University, Korea)
±³À°½Ã°£ 09-12 Room 5 15:40~16:00 Effect of breakfast consumption and meal time regularity on nutrient intake and cardiometabolic health in Korean adults Oh Yoen Kim(Dong-a University, Korea)
±³À°½Ã°£ 09-12 Room 5 16:00~16:20 Mesenchymal stem cell-mediated therapy of peripheral artery disease is stimulated by a lamin A-progerin binding inhibitor Jae Ho Kim(Pusan National University, Korea)
±³À°½Ã°£ 09-12 Room 5 16:20~16:40 Phosphorylation in novel mitochondrial creatine kinase tyrosine residues render cardioprotection against hypoxia/reoxygenation injury Jin Han(Inje University, Korea)
ÈÞ½Ä 09-12 16:40~16:50 Break ()
±âŸ 09-12 ALL 16:50~17:00 Closing Remark ()